C4 Therapeutics (CCCC) Earnings Date, Estimates & Call Transcripts $1.58 +0.11 (+7.48%) Closing price 04:00 PM EasternExtended Trading$1.54 -0.04 (-2.53%) As of 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock C4 Therapeutics Earnings Summary C4 Therapeutics issued Q1 2025 earnings on May 7, 2025, reporting an EPS of -$0.37, which beat analysts' consensus estimates of -$0.48 by $0.11. Quarterly revenue was reported to be $7.20 million, above analyst estimates of $3.54 million. With a trailing EPS of -$1.47, C4 Therapeutics' earnings are expected to decrease next year, from ($1.52) to ($1.70) per share. Upcoming Q2 Earnings DateMay. 14Before Market OpensEstimatedConsensus EPS (May. 7) -$0.48 Actual EPS (May. 7) -$0.37 Beat By $0.11 Actual Revenue (May. 7) $7.20MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)CCCC Upcoming EarningsC4 Therapeutics' next earnings date is estimated for Wednesday, May 14, 2025, based on past reporting schedules. Powered by Get C4 Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on C4 Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCCCC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CCCC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. C4 Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$0.43-$0.43-$0.43Q3 20251-$0.48-$0.48-$0.48Q4 20251-$0.52-$0.52-$0.52 C4 Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/14/2025(Estimated)--------5/7/2025Q1 2025-$0.48-$0.37+$0.11-$0.37$3.54M$7.20M2/27/2025Q4 2024-$0.44-$0.49 -$0.05-$0.49$4.43M$5.18M10/31/2024--$0.40-$0.35+$0.05-$0.35$5.95M$15.36M8/1/2024--$0.37-$0.26+$0.11-$0.26$6.88M$12.01M5/8/2024Q1 2024-$0.41-$0.41--$0.41$10.93M$3.04M2/22/2024Q4 2023-$0.67-$0.68 -$0.01-$0.68$5.23M$3.26M11/1/2023Q3 2023-$0.65-$0.55+$0.10-$0.55$6.94M$11.07M8/8/2023Q2 2023-$0.74-$0.73+$0.01-$0.73$8.65M$2.66M C4 Therapeutics Earnings - Frequently Asked Questions When is C4 Therapeutics's earnings date? C4 Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 14th, 2025 based off last year's report dates. Learn more on CCCC's earnings history. Did C4 Therapeutics beat their earnings estimates last quarter? In the previous quarter, C4 Therapeutics (NASDAQ:CCCC) reported ($0.37) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.48) by $0.11. Learn more on analysts' earnings estimate vs. CCCC's actual earnings. How much revenue does C4 Therapeutics generate each year? C4 Therapeutics (NASDAQ:CCCC) has a recorded annual revenue of $35.58 million. How much profit does C4 Therapeutics generate each year? C4 Therapeutics (NASDAQ:CCCC) has a recorded net income of -$132.49 million. CCCC has generated -$1.47 earnings per share over the last four quarters. What is C4 Therapeutics's EPS forecast for next year? C4 Therapeutics's earnings are expected to decrease from ($1.52) per share to ($1.70) per share in the next year. More Earnings Resources from MarketBeat Related Companies VERV Earnings Date AMLX Earnings Date MAZE Earnings Date ETON Earnings Date SAGE Earnings Date PGEN Earnings Date ZVRA Earnings Date PRTA Earnings Date SANA Earnings Date ALT Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? This page (NASDAQ:CCCC) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredDrop these 5 stocks now!You think the volatility is over? Think again … Because it’s just getting started. In fact, according...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C4 Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share C4 Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CCCC Stock Free CCCC Stock Alerts